CureMint, Inc.® is a health care and SaaS startup providing a spend management platform tailored for dental organizations, aiming to facilitate rapid growth. Founded in 2017, the company's cloud-based source-to-pay platform consolidates procurement management into a singular, accessible interface. The Procure module simplifies the ordering process for office staff while empowering managers with comprehensive oversight. On the other hand, the Pay module targets the costly blind spots between procurement and accounts payable departments, effectively enhancing collaboration and streamlining A/P processes. Notably, the company secured a Series B investment from Triangle Tweener Fund on 01 January 2024, signifying investor confidence in CureMint's value proposition and market potential.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series B | Unknown | 1 | 01 Jan 2024 | |
Series A | Unknown | 1 | 11 Jan 2023 | |
Seed Round | Unknown | 1 | 05 Oct 2022 | |
Debt Financing | $550.00K | - | 20 May 2022 | |
Seed Round | $2.20M | 7 | Thomas A. Sharpe, Richard Hulme +1 | 20 Oct 2021 |
No recent news or press coverage available for CureMint, Inc.®.